A flexible docking scheme efficiently captures the energetics of glycan-cyanovirin binding

Biophysical Journal

Volumn 106, Issue 5, 2014, Pages 1142-1151

  Bolia, Ashini ^a   Woodrum, Brian W ^a   Cereda, Angelo ^a   Ruben, Melissa A ^a   Wang, Xu ^a   Ozkan, S Banu ^a   Ghirlanda, Giovanna ^a  

^a ARIZONA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; BACTERIAL PROTEIN; CARRIER PROTEIN; CYANOVIRIN N; POLYSACCHARIDE;

AMINO ACID SEQUENCE; ARTICLE; CHEMISTRY; ENZYME SPECIFICITY; GENETICS; METABOLISM; MOLECULAR DOCKING; MOLECULAR GENETICS; POINT MUTATION; PROTEIN TERTIARY STRUCTURE; THERMODYNAMICS;

AMINO ACID SEQUENCE; ANTI-HIV AGENTS; BACTERIAL PROTEINS; CARRIER PROTEINS; MOLECULAR DOCKING SIMULATION; MOLECULAR SEQUENCE DATA; POINT MUTATION; POLYSACCHARIDES; PROTEIN STRUCTURE, TERTIARY; SUBSTRATE SPECIFICITY; THERMODYNAMICS;

EID: 84901743765     PISSN: 00063495     EISSN: 15420086     Source Type: Journal    
DOI: 10.1016/j.bpj.2014.01.040     Document Type: Article

References (58)

1. T. Mori, and M.R. Boyd Cyanovirin-N, a potent human immunodeficiency virus-inactivating protein, blocks both CD4-dependent and CD4-independent binding of soluble gp120 (sgp120) to target cells, inhibits sCD4-induced binding of sgp120 to cell-associated CXCR4, and dissociates bound sgp120 from target cells Antimicrob. Agents Chemother. 45 2001 664 672
2. M.T. Esser, and T. Mori J.D. Lifson Cyanovirin-N binds to gp120 to interfere with CD4-dependent human immunodeficiency virus type 1 virion binding, fusion, and infectivity but does not affect the CD4 binding site on gp120 or soluble CD4-induced conformational changes in gp120 J. Virol. 73 1999 4360 4371
3. I. Botos, and A. Wlodawer Cyanovirin-N: a sugar-binding antiviral protein with a new twist Cell. Mol. Life Sci. 60 2003 277 287
4. L.G. Barrientos, and B.R. O'Keefe M.R. Boyd Cyanovirin-N binds to the viral surface glycoprotein, GP1,2 and inhibits infectivity of Ebola virus Antiviral Res. 58 2003 47 56
5. A.J. Bolmstedt, and B.R. O'Keefe M.R. Boyd Cyanovirin-N defines a new class of antiviral agent targeting N-linked, high-mannose glycans in an oligosaccharide-specific manner Mol. Pharmacol. 59 2001 949 954
6. J. Balzarini Targeting the glycans of glycoproteins: a novel paradigm for antiviral therapy Nat. Rev. Microbiol. 5 2007 583 597
7. C.N. Scanlan, and J. Offer R.A. Dwek Exploiting the defensive sugars of HIV-1 for drug and vaccine design Nature 446 2007 1038 1045
8. R. Fromme, and Z. Katiliene G. Ghirlanda Conformational gating of dimannose binding to the antiviral protein cyanovirin revealed from the crystal structure at 1.35 A resolution Protein Sci. 17 2008 939 944
9. R. Fromme, and Z. Katiliene G. Ghirlanda A monovalent mutant of cyanovirin-N provides insight into the role of multiple interactions with gp120 for antiviral activity Biochemistry 46 2007 9199 9207
10. Y. Liu, and J.R. Carroll G. Ghirlanda Multivalent interactions with gp120 are required for the anti-HIV activity of Cyanovirin Biopolymers 92 2009 194 200
11. E. Matei, and A. Zheng A.M. Gronenborn Anti-HIV activity of defective cyanovirin-N mutants is restored by dimerization J. Biol. Chem. 285 2010 13057 13065
12. J.R. Keeffe, and P.N.P. Gnanapragasam S.L. Mayo Designed oligomers of cyanovirin-N show enhanced HIV neutralization Proc. Natl. Acad. Sci. USA 108 2011 14079 14084
13. V. Patsalo, D.P. Raleigh, and D.F. Green Rational and computational design of stabilized variants of cyanovirin-N that retain affinity and specificity for glycan ligands Biochemistry 50 2011 10698 10712
14. L.M.I. Koharudin, and A.R. Viscomi A.M. Gronenborn The evolutionarily conserved family of cyanovirin-N homologs: structures and carbohydrate specificity Structure 16 2008 570 584
15. C.A. Bewley, and S. Otero-Quintero The potent anti-HIV protein cyanovirin-N contains two novel carbohydrate binding sites that selectively bind to Man(8) D1D3 and Man(9) with nanomolar affinity: implications for binding to the HIV envelope protein gp120 J. Am. Chem. Soc. 123 2001 3892 3902
16. E. Matei, W. Furey, and A.M. Gronenborn Solution and crystal structures of a sugar binding site mutant of cyanovirin-N: no evidence of domain swapping Structure 16 2008 1183 1194
17. Y.K. Fujimoto, and R.N. Terbush D.F. Green Computational models explain the oligosaccharide specificity of cyanovirin-N Protein Sci. 17 2008 2008 2014
18. C.A. Bewley Solution structure of a cyanovirin-N:Man α1-2Man α complex: structural basis for high-affinity carbohydrate-mediated binding to gp120 Structure 9 2001 931 940
19. I. Botos, and B.R. O'Keefe A. Wlodawer Structures of the complexes of a potent anti-HIV protein cyanovirin-N and high mannose oligosaccharides J. Biol. Chem. 277 2002 34336 34342
20. C.J. Margulis Computational study of the dynamics of mannose disaccharides free in solution and bound to the potent anti-HIV virucidal protein cyanovirin J. Phys. Chem. B 109 2005 3639 3647
21. I.I. Vorontsov, and O. Miyashita Solution and crystal molecular dynamics simulation study of m4-cyanovirin-N mutants complexed with di-mannose Biophys. J. 97 2009 2532 2540
22. C.A. Bewley, S. Kiyonaka, and I. Hamachi Site-specific discrimination by cyanovirin-N for α-linked trisaccharides comprising the three arms of Man(8) and Man(9) J. Mol. Biol. 322 2002 881 889
23. S.R. Shenoy, and L.G. Barrientos M.R. Boyd Multisite and multivalent binding between cyanovirin-N and branched oligomannosides: calorimetric and NMR characterization Chem. Biol. 9 2002 1109 1118
24. C. Sandström, and O. Berteau A.M. Gronenborn Atomic mapping of the interactions between the antiviral agent cyanovirin-N and oligomannosides by saturation-transfer difference NMR Biochemistry 43 2004 13926 13931
25. B.W. Woodrum, and J.D. Maxwell G. Ghirlanda The antiviral lectin cyanovirin-N: probing multivalency and glycan recognition through experimental and computational approaches Biochem. Soc. Trans. 41 2013 1170 1176
26. C. Atilgan, and Z.N. Gerek A.R. Atilgan Manipulation of conformational change in proteins by single-residue perturbations Biophys. J. 99 2010 933 943
27. Z.N. Gerek, and S.B. Ozkan A flexible docking scheme to explore the binding selectivity of PDZ domains Protein Sci. 19 2010 914 928
28. Z.N. Gerek, and S.B. Ozkan Change in allosteric network affects binding affinities of PDZ domains: analysis through perturbation response scanning PLOS Comput. Biol. 7 2011 e1002154
29. A. Bolia, and Z.N. Gerek K.K. Dev The binding affinities of proteins interacting with the PDZ domain of PICK1 Proteins 80 2012 1393 1408
30. J. Xia, and C.J. Margulis Computational study of the conformational structures of saccharides in solution based on J couplings and the "fast sugar structure prediction software" Biomacromolecules 10 2009 3081 3088
31. J. Xia, C.J. Margulis, and D.A. Case Searching and optimizing structure ensembles for complex flexible sugars J. Am. Chem. Soc. 133 2011 15252 15255
32. S.K. Ramadugu, and Y.-H. Chung C.J. Margulis When sugars get wet. A comprehensive study of the behavior of water on the surface of oligosaccharides J. Phys. Chem. B 113 2009 11003 11015
33. H.M. Berman, and J. Westbrook P.E. Bourne The Protein Data Bank Nucleic Acids Res. 28 2000 235 242
34. N. Guex, and M.C. Peitsch SWISS-MODEL and the Swiss-PdbViewer: an environment for comparative protein modeling Electrophoresis 18 1997 2714 2723
35. Y. Sugita, and Y. Okamoto Replica-exchange molecular dynamics method for protein folding Chem. Phys. Lett. 314 1999 141 151
36. V. Hornak, and R. Abel C. Simmerling Comparison of multiple Amber force fields and development of improved protein backbone parameters Proteins 65 2006 712 725
37. V. Tsui, and D.A. Case Theory and applications of the generalized Born solvation model in macromolecular simulations Biopolymers 56 2000-2001 275 291
38. C. Atilgan, and A.R. Atilgan Perturbation-response scanning reveals ligand entry-exit mechanisms of ferric binding protein PLOS Comput. Biol. 5 2009 e1000544
39. M. Ikeguchi, and J. Ueno A. Kidera Protein structural change upon ligand binding: linear response theory Phys. Rev. Lett. 94 2005 078102
40. Z. Nevin Gerek, S. Kumar, and S. Banu Ozkan Structural dynamics flexibility informs function and evolution at a proteome scale Evol. Appl 6 2013 423 433
41. I. Bahar, and T.R. Lezon E. Eyal Global dynamics of proteins: bridging between structure and function Annu. Rev. Biophys 39 2010 23 42
42. P.A. Kollman, R. Dixon, W. Cornell, T. Fox, and C. Chipot et al. The development/application of a "minimalist"organic/biochemical molecular mechanic force field using a combination of ab initio calculations and experimental data Comput. Simul. Biomol. Syst. 3 1997 83 96
43. V. Tsui, and D.A. Case Molecular dynamics simulations of nucleic acids with a generalized Born solvation model J. Am. Chem. Soc. 122 2000 2489 2498
44. I.W. Davis, and D. Baker RosettaLigand docking with full ligand and receptor flexibility J. Mol. Biol. 385 2009 381 392
45. J. Meiler, and D. Baker ROSETTALIGAND: protein-small molecule docking with full side-chain flexibility Proteins 65 2006 538 548
46. R. Wang, L. Lai, and S. Wang Further development and validation of empirical scoring functions for structure-based binding affinity prediction J. Comput. Aided Mol. Des. 16 2002 11 26
47. B.T. Farmer 2nd, and K.L. Constantine L. Mueller Localizing the NADP+ binding site on the MurB enzyme by NMR Nat. Struct. Biol. 3 1996 995 997
48. M.P. Williamson Using chemical shift perturbation to characterise ligand binding Prog. Nucl. Magn. Reson. Spectrosc. 73 2013 1 16
49. L.G. Barrientos, and E. Matei A.M. Gronenborn Dissecting carbohydrate-Cyanovirin-N binding by structure-guided mutagenesis: functional implications for viral entry inhibition Protein Eng. Des. Sel. 19 2006 525 535
50. L.G. Barrientos, and J.M. Louis A.M. Gronenborn The domain-swapped dimer of cyanovirin-N is in a metastable folded state: reconciliation of X-ray and NMR structures Structure 10 2002 673 686
51. R. Percudani, B. Montanini, and S. Ottonello The anti-HIV cyanovirin-N domain is evolutionarily conserved and occurs as a protein module in eukaryotes Proteins 60 2005 670 678
52. C.A. Bewley, and S. Shahzad-Ul-Hussan Characterizing carbohydrate-protein interactions by nuclear magnetic resonance spectroscopy Biopolymers 99 2013 796 806
53. Y.K. Fujimoto, and D.F. Green Carbohydrate recognition by the antiviral lectin cyanovirin-N J. Am. Chem. Soc. 134 2012 19639 19651
54. I.I. Vorontsov, and O. Miyashita Crystal molecular dynamics simulations to speed up MM/PB(GB)SA evaluation of binding free energies of di-mannose deoxy analogs with P51G-m4-Cyanovirin-N J. Comput. Chem. 32 2011 1043 1053
55. J.J. Gray, and S.E. Moughon D. Baker Protein-protein docking predictions for the CAPRI experiment Proteins 52 2003 118 122
56. E. Matei, and J.M. Louis A.M. Gronenborn NMR solution structure of a cyanovirin homolog from wheat head blight fungus Proteins 79 2011 1538 1549
57. M. Totrov, and R. Abagyan Flexible ligand docking to multiple receptor conformations: a practical alternative Curr. Opin. Struct. Biol. 18 2008 178 184
58. N. Andrusier, and E. Mashiach H.J. Wolfson Principles of flexible protein-protein docking Proteins 73 2008 271 289